List of pathologies – MicrogenChip 180K
Nowadays Molecular Karyotyping is considered a first-tier diagnostic test for individuals with unexplained mental retardation, developmental delay, autism spectrum disorders, epilepsy or multiple congenital anomalies.
It has been demonstrated that molecular karyotype guarantees a much higher diagnostic yield (15%-20%) than conventional karyotype (~3%).
The MicrogenChip 180K and MicrogenChip 180K CGH+SNP arrays have been specifically designed for the application of molecular karyotype in postnatal diagnosis. These platforms are continuously updated with new disease genes in order to improve the sensitivity of the array-CGH analysis.
Below we provide a detailed brochure with a list of diseases investigated by the MicrogenChip 180K platform.